Scorpius Holdings Inc. · OTC:SCPX
Scorpius — NightHawk Biosciences — Investor Presentation (November 2022)
10 slides from Scorpius's investor presentation, Nov 14, 2022
Slide 1: NightHawk Biosciences Corporate Presentation November 2022
NIGHTHAWKBIOSCIENCESCORPORATE PRESENTATIONNovember 2022
Slide 2: Forward-looking statements
This presentation includes statements that are, or may be deemed, ‘‘forward-looking statements’’ within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, includ
Slide 3: Snapshot of NightHawk
3 Snapshot of N IGHT H AWK US biopharmaceutical company with fully integrated ecosystem to expeditiously streamline drug development•Wholly owned GMP biomanufacturing and bioanalytical services support internal and revenue-generating client clinical and commercial projects•In-house discovery, clinic
Slide 4: NightHawk Ecosystem
4 N IGHT H AWK Ecosystem Streamlining Development and Manufacturing to Commercialize Innovative Medical Countermeasures OUR ECOSYSTEM DiscoveryBiomanufacturingDevelopment / Commercial
Slide 5: Scorpion Biological Services
Scorpion Biological Services GMP Biomanufacturing and Bioanalytical Services Supporting Clinical and Commercial Projects Providing GMP biomanufacturing, cell and immuno-assay development, and bioanalytical lab services•Dedicated capacity to accelerate NightHawk clinical and commercial efforts •Contr
Slide 6: Skunkworx Bio Discovery Sciences
Skunkworx Bio Discovery Sciences Unique Hotspot discovery approach based on Pocket Biologics •Novel, highly diverse, proprietary compound libraries used to identify small proteins and human antibodies which bind to critical druggable targets•Shifts the paradigm of drug discovery by integrating biolo
Slide 7: Elusys Therapeutics Medical Countermeasures
Elusys Therapeutics Medical Countermeasures Development and commercialization of biologics to combat unmet and emerging biothreats•Strong record of delivering countermeasures to the US National Stockpile and Public Health Agency of CA•Renowned biothreat advisory board providing counsel on biodefense
Slide 8: Biothreat Advisory Board
Biothreat Advisory Board Renowned Experts Providing Counsel on NIGHTHAWK’s Medical Countermeasure Initiatives 8 Andrew Weber Jack Kingston Dr. Gregory Koblentz Mark Pryor Former Deputy Asst. Sec. of Defense for Countering Weapons of Mass DestructionFormer Asst. Sec. of Defense for Nuclear, Chemical
Slide 9: NightHawk Highlights
N IGHT H AWK Highlights Fully Integrated Ecosystem Streaming the Development and Delivery of Innovative Medical Countermeasures Scorpion Biological Services–Biomanufacturing and bioanalytical services•Large biologics CDMO currently supporting internal and external revenue-generating client projects•
Slide 10: 10NIGHTHAWKBIOSCIENCES
10NIGHTHAWKBIOSCIENCES
NightHawk Biosciences — Investor Presentation (November 2022) on 6ix